Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation.
<h4>Background</h4>Tumour suppressor genes are often transcriptionally silenced by promoter hypermethylation, and recent research has implicated alterations in chromatin structure as the mechanistic basis for this repression. In addition to DNA methylation, other epigenetic post-translat...
Guardado en:
Autores principales: | María F Montenegro, Magali Sáez-Ayala, Antonio Piñero-Madrona, Juan Cabezas-Herrera, José Neptuno Rodríguez-López |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/17eabdbfda8d4ce0be8e713fa74c05ba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data.
por: Yong Jiang, et al.
Publicado: (2012) -
A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis
por: Ines Jeric, et al.
Publicado: (2016) -
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
por: Swati Dabral, et al.
Publicado: (2019) -
The tumour suppressor APC promotes HIV-1 assembly via interaction with Gag precursor protein
por: Kei Miyakawa, et al.
Publicado: (2017) -
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
por: Jiqiu Cheng, et al.
Publicado: (2017)